Skip to content

Effect of Modified Complete Decongestive Therapy on Lower Limbs Fibrosis Post Cellulitis

Effect of Modified Complete Decongestive Therapy on Lower Limbs Fibrosis Post Cellulitis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05661123
Enrollment
30
Registered
2022-12-22
Start date
2023-09-20
Completion date
2024-06-30
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Lymphedema, Fibrosis, Cellulitis of Leg

Keywords

Lymphedema, complete decongestive therapy, kinesio tape

Brief summary

this study will be designed to investigate the therapeutic benefits of kinesio tape in combination to complete decongestive therapy on limb volume , skin fibrosis, functional capacity ,ankle range of motion, lymphedema associated symptoms (pain, tightness, heaviness and hardness) and quality of life in patients with lower limbs fibrosis post cellulitis ,as well as finding out a physical therapy approach that has positive effect in treatment and care such cases which would enhance the physical therapy field.

Detailed description

Lymphedema patient need a rehabilitative intervention in two phases : decongestion phase to reduce edema volume , improve the skin extensibility and provide him a better quality of life, followed by the maintenance phase to keep the outcomes. When we use the kinesio tape in addition to the complete decongestive therapy, the patient will experience a better improvement in the edema volume and the skin extensibility within a shorter period of time , a lesser number of sessions and a lower cost. So, the patient will have a better quality of life and could be a productive person in the society.

Interventions

1. Education. 2. Skin care . 3. Pneumatic compression device . 4. Manual lymph draining . 5. Multilayer short stretch compression bandages. 6. Exercises.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
45 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

The patient will be according the following criteria:- 1. Males and females with Lower limb lymphedema Stage 2. 2. Age will range from45 to 55years old. 3. BMI \<40 (kg/m2). 4. All patients will be clinically and medically stable when attending the study. 5. Patients free from any acute conditions. 6. Post cellulitis for at least 2 weeks.

Exclusion criteria

1. Unstable cardiovascular problems. 2. Altered mental status or poor cognition. 3. Lower limb ischemia (ABI ≤0.8). 4. Lower limb lymphedema stage 3&4. 5. Acute deep venous thrombosis. 6. Any acute infection. 7. Patients with orthopedic or neurological limitations to exercise. 8. Any lower limb acute ulcer or arterial wounds.

Design outcomes

Primary

MeasureTime frameDescription
To assess limb volume6 weeksusing Circumferential tape measurement to measure round measurements in cm at the beginning of the study then every 3 sessions
To assess skin extensibility6 weeksusing tonometer at the beginning of the study and at last session after 6 weeks
To evaluate ankle range of motion6 weeksusing digital goniometer at the ankle joint to assess the dorsi flexion degree at the beginning of the study and at the last session
To evaluate patient quality of life6 weeksusing Lymphedema life impact scale in form of 18 questions every question' answer from 0 ( no symptoms) to 4 ( sever symptoms) at the beginning of the study and at the end of sessions

Countries

Egypt

Contacts

Primary ContactEva Nakhla
dr-evamagdy@hotmail.comm0201220264801

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026